CervoMed publishes phase 2b trial results for DLB treatment By Investing.com Investing.com IndiaNeflamapimod for Dementia With Lewy Bodies Misses End Point, Subgroup Signal Emerges Psychiatric TimesCervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB) Yahoo FinanceCervoMed publishes two peer-reviewed studies on DLB drug neflamapimod StreetInsider
CervoMed publishes phase 2b trial results for DLB treatment By Investing.com Investing.com IndiaNeflamapimod for Dementia With Lewy Bodies Misses End Point, Subgroup Signal Emerges Psychiatric TimesCervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB) Yahoo FinanceCervoMed publishes two peer-reviewed studies on DLB drug neflamapimod StreetInsider
